Clinical Trial Update: AMIOdarone vs. Catheter Ablation for Prevention of Recurrent Symptomatic Atrial Fibrillation [Phase 4]

View source ↗

Summary

Phase 4 trial comparing amiodarone versus catheter ablation for prevention of recurrent symptomatic atrial fibrillation; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Amiodarone (amiodarone)

Snippet

Sponsor: Population Health Research Institute | Conditions: Atrial Fibrillation | Phase 4 | Status: TERMINATED